Glickman, Richard

Insider profile

Performance

Overall performance
3.4

Performance over holding periods
3.4
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Glickman, Richard's trades of Eupraxia Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-09-30 2025-09-23 B Purchase
98,908 +49.9%
360.10
US$1,707,188
98,908 +49.9% 360.10 US$1,707,188
2025-09-30 2025-09-23 B Purchase
32,946 -13.9%
498.54
US$4,526,494
32,946 -13.9% 498.54 US$4,526,494
2023-08-20 2023-08-18 B Purchase
156 -12.4%
308.90
CA$4,504,224
156 -12.4% 308.90 CA$4,504,224